MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$45,530K
EPS
-$14.35
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
23,276
General and administrative
19,875
Impairment of long-lived assets
6,145
Loss from operations
-49,296
Other income (expense), net
3,774
Net loss
-45,522
Unrealized gain (loss) on marketable securities
-8
Comprehensive loss
-45,530
Basic EPS
-14.35
Diluted EPS
-14.35
Basic Average Shares
3,172,870
Diluted Average Shares
3,172,870
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$45,530K Net loss-$45,522K Unrealized gain (loss) onmarketable securities-$8K Other income(expense), net$3,774K Loss from operations-$49,296K Research and development$23,276K General andadministrative$19,875K Impairment of long-livedassets$6,145K

Passage BIO, Inc. (PASG)

Passage BIO, Inc. (PASG)